Root Cause Analysis: Examining Structural Racism and SDoH to Combat Inequities in Cancer CarePremiere Date: Monday, July 11, 2022
This activity offers CE credit for:%>
- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, July 11, 2023
|Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (Moderator)
Clinical Professor of Medicine and Medical Oncology
Department of Medical Oncology
Director, Center to Eliminate Cancer Disparities
Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson
116th President of the National Medical Association
|Narjust Florez (Duma), MD
Associate Director, The Cancer Care Equity Program
Thoracic Oncologist, Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Harvard Medical School
|Brian M. Rivers, PhD, MPH
Director, Cancer Health Equity Institute
Professor, Community Health and Preventive Medicine
Morehouse School of Medicine
Institutional and structural racism, those social inequities deeply engrained or built into a society, include policies and conditions that disadvantage a group. These factors, whether intended or not, create inequities, such as reduced funding for remote or under-resourced cancer care centers, poor or no insurance for patients, few people from under-resourced communities within health care, and low clinical trial participation by members of these communities. Additionally, unconscious or conscious bias from health care professionals compounds structural barriers. To address systemic disparities in cancer care and to deliver high-quality care to all patients, health systems and institutions must recognize those factors that create inequities within their community. Analyses use patient-level quality measures to identify institution-specific gaps, and disparities in care delivery and outcomes, and use systems-level factors related to race, ethnicity, sexual orientation, gender, insurance status, geography, and more. By respecting and welcoming opportunities for introspection, institutions and HCPs can change their organizations and practices to improve care and outcomes for everyone.
In this CME Outfitters OnDemand Webcast, expert faculty will discuss how structural inequities rooted within health systems impact members of historically marginalized groups. They will describe major health care barriers and outline how institutional analyses can help identify and rectify these disparities. Resources to improve health equity, including partnerships with organizations such as Project ECHO, will demonstrate how these programs can be implemented. Finally, opportunities for introspection within the health care systems will be presented.
Supported by educational grants from Bristol Myers Squibb and Merck Sharpe & Dohme Corp.
Physicians, PAs, nurse practitioners, nurses, nurse navigators, pharmacists, social workers, and case managers specializing in oncology, emergency medicine and/or primary care
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Dr. Mitchell reports the following financial relationships:
Advisory Board: Corvus Pharmaceuticals, Inc.
Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo Inc.
Dr. Florez reports the following financial relationships:
Advisory board: AstraZeneca; DSI; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Mirati Therapeutics, Inc.; and Pfizer Inc.
Speakers Bureau: NeoGenomics
Dr. Rivers reports no financial relationships.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).